103 related articles for article (PubMed ID: 20564128)
1. Understanding the variation in treatment intensity among patients with early stage bladder cancer.
Hollingsworth JM; Zhang Y; Krein SL; Ye Z; Hollenbeck BK
Cancer; 2010 Aug; 116(15):3587-94. PubMed ID: 20564128
[TBL] [Abstract][Full Text] [Related]
2. Understanding bladder cancer death: tumor biology versus physician practice.
Morris DS; Weizer AZ; Ye Z; Dunn RL; Montie JE; Hollenbeck BK
Cancer; 2009 Mar; 115(5):1011-20. PubMed ID: 19152434
[TBL] [Abstract][Full Text] [Related]
3. Regional differences in early stage bladder cancer care and outcomes.
Skolarus TA; Ye Z; Zhang S; Hollenbeck BK
Urology; 2010 Aug; 76(2):391-6. PubMed ID: 20394976
[TBL] [Abstract][Full Text] [Related]
4. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.
Schrag D; Mitra N; Xu F; Rabbani F; Bach PB; Herr H; Begg CB
Urology; 2005 Jun; 65(6):1118-25. PubMed ID: 15922428
[TBL] [Abstract][Full Text] [Related]
5. Identifying better practices for early-stage bladder cancer.
Hollingsworth JM; Zhang YS; Miller DC; Skolarus TA; Wood DP; Lee CT; Montie JE; Hollenbeck BK
Med Care; 2011 Dec; 49(12):1112-7. PubMed ID: 21979371
[TBL] [Abstract][Full Text] [Related]
6. Patient time costs associated with cancer care.
Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
Konety BR; Joslyn SA
J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
[TBL] [Abstract][Full Text] [Related]
8. Provider treatment intensity and outcomes for patients with early-stage bladder cancer.
Hollenbeck BK; Ye Z; Dunn RL; Montie JE; Birkmeyer JD
J Natl Cancer Inst; 2009 Apr; 101(8):571-80. PubMed ID: 19351919
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
[TBL] [Abstract][Full Text] [Related]
10. Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program.
Konety BR; Dhawan V; Allareddy V; Joslyn SA
J Urol; 2005 Jun; 173(6):2085-9. PubMed ID: 15879848
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.
Ramsey SD; Howlader N; Etzioni RD; Donato B
J Clin Oncol; 2004 Dec; 22(24):4971-8. PubMed ID: 15611512
[TBL] [Abstract][Full Text] [Related]
12. Clinical model of cost of bladder cancer in the elderly.
Cooksley CD; Avritscher EB; Grossman HB; Sabichi AL; Dinney CP; Pettaway C; Elting LS
Urology; 2008 Mar; 71(3):519-25. PubMed ID: 18342201
[TBL] [Abstract][Full Text] [Related]
13. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
14. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
15. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older.
Hollenbeck BK; Miller DC; Taub D; Dunn RL; Underwood W; Montie JE; Wei JT
Urology; 2004 Aug; 64(2):292-7. PubMed ID: 15302481
[TBL] [Abstract][Full Text] [Related]
16. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.
Konety BR; Joslyn SA; O'Donnell MA
J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819
[TBL] [Abstract][Full Text] [Related]
17. The effect of changes in Medicare reimbursement on the practice of office and hospital-based endoscopic surgery for bladder cancer.
Hemani ML; Makarov DV; Huang WC; Taneja SS
Cancer; 2010 Mar; 116(5):1264-71. PubMed ID: 20143327
[TBL] [Abstract][Full Text] [Related]
18. Discharge practice patterns following cystectomy for bladder cancer: evidence for the shifting of the burden of care.
Taub DA; Dunn RL; Miller DC; Wei JT; Hollenbeck BK
J Urol; 2006 Dec; 176(6 Pt 1):2612-7; discussion 2617-8. PubMed ID: 17085172
[TBL] [Abstract][Full Text] [Related]
19. Optimal management of high-risk T1G3 bladder cancer: a decision analysis.
Kulkarni GS; Finelli A; Fleshner NE; Jewett MA; Lopushinsky SR; Alibhai SM
PLoS Med; 2007 Sep; 4(9):e284. PubMed ID: 17896857
[TBL] [Abstract][Full Text] [Related]
20. Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years.
Pollack LA; Adamache W; Ryerson AB; Eheman CR; Richardson LC
Cancer; 2009 Nov; 115(22):5284-95. PubMed ID: 19685532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
